AAAAAA

   
Results: 1-10 |
Results: 10
Combined pituitary hormone deficiency due to the F135C human Pit-1 (pituitary-specific factor 1) gene mutation: Functional and structural correlates
Authors: Vallette-Kasic, S Pellegrini-Bouiller, I Sampieri, F Gunz, G Diaz, A Radovick, S Enjalbert, A Brue, T
Citation: S. Vallette-kasic et al., Combined pituitary hormone deficiency due to the F135C human Pit-1 (pituitary-specific factor 1) gene mutation: Functional and structural correlates, MOL ENDOCR, 15(3), 2001, pp. 411-420
A pituitary cell-restricted T box factor, Tpit, activates POMC transcription in cooperation with Pitx homeoproteins
Authors: Lamolet, B Pulichino, AM Lamonerie, T Gauthier, Y Brue, T Enjalbert, A Drouin, J
Citation: B. Lamolet et al., A pituitary cell-restricted T box factor, Tpit, activates POMC transcription in cooperation with Pitx homeoproteins, CELL, 104(6), 2001, pp. 849-859
PROP1 gene screening in patients with multiple pituitary hormone deficiency reveals two sites of hypermutability and a high incidence of corticotrophdeficiency
Authors: Vallette-Kasic, S Barlier, A Teinturier, C Diaz, A Manavela, M Berthezene, F Bouchard, P Chaussain, JL Brauner, R Pellegrini-Bouiller, I Jaquet, P Enjalbert, A Brue, T
Citation: S. Vallette-kasic et al., PROP1 gene screening in patients with multiple pituitary hormone deficiency reveals two sites of hypermutability and a high incidence of corticotrophdeficiency, J CLIN END, 86(9), 2001, pp. 4529-4535
Markers of tumor invasion are major predictive factors for the long-term outcome of corticotroph microadenomas treated by transsphenoidal adenomectomy
Authors: Vallette-Kasic, S Dufour, H Mugnier, M Trouillas, J Valdes-Socin, H Caron, P Morange, S Girard, N Grisoli, F Jaquet, P Brue, T
Citation: S. Vallette-kasic et al., Markers of tumor invasion are major predictive factors for the long-term outcome of corticotroph microadenomas treated by transsphenoidal adenomectomy, EUR J ENDOC, 143(6), 2000, pp. 761-768
Pituitary development: fundamental aspects and functional consequences
Authors: Brue, T
Citation: T. Brue, Pituitary development: fundamental aspects and functional consequences, ANN ENDOCR, 61(5), 2000, pp. 476-476
Pituitary development and abnormalities of transcription factors
Authors: Barlier, A Vallette-Kasic, S Manavela, M Perez, M Diaz, A Pellegrini-Bouiller, I Enjalbert, A Brue, T
Citation: A. Barlier et al., Pituitary development and abnormalities of transcription factors, ANN ENDOCR, 61(3), 2000, pp. 201-207
Defective retinoic acid regulation of the Pit-1 gene enhancer: A novel mechanism of combined pituitary hormone deficiency
Authors: Cohen, LE Zanger, K Brue, T Wondisford, FE Radovick, S
Citation: Le. Cohen et al., Defective retinoic acid regulation of the Pit-1 gene enhancer: A novel mechanism of combined pituitary hormone deficiency, MOL ENDOCR, 13(3), 1999, pp. 476-484
An ultrarapid prognostic index in microprolactinoma surgery
Authors: Guieu, R Dufour, H Grisoli, F Jaquet, P Guieu, Y Rosso, JP Munier, M Dicostanzo, V Brue, T Enjalbert, A Begoud, D Rochat, H
Citation: R. Guieu et al., An ultrarapid prognostic index in microprolactinoma surgery, J NEUROSURG, 90(6), 1999, pp. 1037-1041
Transcription factors of the anterior pituitary and combined hypopituitarism
Authors: Vallette, S Pellegrini-Bouiller, I Jaquet, P Enjalbert, A Brue, T
Citation: S. Vallette et al., Transcription factors of the anterior pituitary and combined hypopituitarism, ANN ENDOCR, 60(3), 1999, pp. 216-223
Somatostatin agonists in the treatment of acromegaly.
Authors: Jaquet, P Morange-Rahos, I Janano, B Moati, P Brue, T
Citation: P. Jaquet et al., Somatostatin agonists in the treatment of acromegaly., ANN ENDOCR, 59(4), 1998, pp. 301-304
Risultati: 1-10 |